Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Non-blinded, Two-way Crossover Study to Assess Bioequivalence Between Finerenone Study Intervention A (Test) and Study Intervention B (Reference) in Healthy Male Adult Participants

NCT07116512 is registered in ClinicalTrials.gov with Bayer as lead sponsor.

NCT NCT07116512
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07116512 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Non-blinded, Two-way Crossover Study to Assess Bioequivalence Between Finerenone Study Intervention A (Test) and Study Intervention B (Reference) in Healthy Male Adult Participants
Lead sponsor
Bayer
Phase
Phase 1
Overall status
Completed
Start date
May 2, 2023
Completion date
July 28, 2023
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers, heart failure with left ventricular ejection fraction greater than or equal to 40 per cent